InsidersTradesSigma
Shanghai Junshi Biosciences Co., Ltd.: directors' dealings · Hong Kong · HKEX
HKEX:shanghai-junshi-biosciences-co-ltd-h-sharesHK·HKEXMcap 23.5Bn€Healthcare
Explore the full insider trade history of Shanghai Junshi Biosciences Co., Ltd., a listed issuer based in Hong Kong. Shares are listed on HK HK, under the authority of HKEX. Operating in the Healthcare sector, Shanghai Junshi Biosciences Co., Ltd. has recorded 5 insider filings. Market capitalisation: €23.5bn. The latest transaction was disclosed on 8 April 2026 — Purchase. Among the most active insiders: Xiong Jun. Every trade is free.
5
Insider Decl.
0
Thresholds
€11m
5 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
22.88 €
Analyst consensus
4 analysts20.23 €Target 29.87 €(+31%)35.08 €
Income statement
Revenue2.50 Bn€
Gross profit1.98 Bn€79% margin
Net income−840.9 M€-24.3% margin
Valuation
PER (forward)-82.3x
P/Book3.5x
Beta0.61
Balance sheet & cash
Market cap23.47 Bn€
Total debt4.14 Bn€
Free Cash Flow−1.28 Bn€
Debt / Equity98%
Profitability & ownership
ROE-13.5%
ROA-3.7%
% insiders19.6%
% institutions17.9%
Last declaration on 8 April 2026
Declarations5 total
Executives●Purchase4HKEX
894,600 shares
ShareXHKG
HKEX:DA20260403E00027·
Ideal exit: 26 Dec 2026 (T+270)
Executives●Purchase4HKEX
1,999,513 shares
ShareXHKG
HKEX:DA20260403E00026·
Ideal exit: 26 Dec 2026 (T+270)
5 of 5 declarations